July 29, 2008 – FDA Advisory Committee Recommends Approval of Actemra (tocilizumab) for the Treatment of Rheumatoid Arthritis.
July 2008 – FDA Advisory Committee Recommends Approval
Announcement Date: July 29, 2008
July 29, 2008 – FDA Advisory Committee Recommends Approval of Actemra (tocilizumab) for the Treatment of Rheumatoid Arthritis.